Studying lupus kidney disease using urine particles
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at tiny particles in urine to better understand and monitor lupus-related kidney problems. It may help find better ways to track the disease without invasive biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 or older
- Includes four groups: people with lupus and kidney issues, people with lupus but no kidney issues, healthy people, and people getting a kidney biopsy
- Must be able and willing to give informed consent
- Should not have other serious health problems that could affect the results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study looks at whether a specific antibody (anti-alpha-actinin) in the blood is linked to active lupus kidney disease. It may help doctors better understand and monitor kidney problems in people with lupus.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at a simple urine test to see if it can show how active lupus nephritis (kidney inflammation caused by lupus) is. It might help doctors monitor the condition without needing repeated biopsies.
This study looks at specific immune antibodies (against C1s, HMGB1, and C1q) in adults with systemic lupus erythematosus, especially when lupus is actively affecting the kidneys. It may help researchers better understand what is driving active lupus and who could benefit from future treatments.
Hear when a new Systemic Lupus Erythematosus Nephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.